盐酸氯胺酮原料药
Search documents
国药现代(600420.SH)子公司盐酸氯胺酮原料药获得上市申请批准
智通财经网· 2025-08-07 08:27
盐酸氯胺酮制剂是一种静脉麻醉药,可作为单一麻醉剂用于无需骨骼肌松弛的诊断和外科手术,也可用 于诱导全身麻醉或者作为其他麻醉剂的补充。 智通财经APP讯,国药现代(600420.SH)发布公告,近日,公司全资子公司国药集团工业有限公司(简称 国药工业)收到国家药品监督管理局核准签发的《化学原料药上市申请批准通知书》,批准原料药盐酸 氯胺酮上市申请。 ...
国药现代:子公司国药工业盐酸氯胺酮原料药获上市批准
Xin Lang Cai Jing· 2025-08-07 08:25
Group 1 - The core point of the article is that China National Pharmaceutical Group Modern has received approval from the National Medical Products Administration for the market application of the raw material drug ketamine hydrochloride [1] - Ketamine hydrochloride is a intravenous anesthetic that can be used as a sole anesthetic for diagnostic and surgical procedures without muscle relaxation, and can also be used for inducing general anesthesia or as a supplement to other anesthetics [1] - The cumulative R&D investment by China National Pharmaceutical Group Industrial for this project is approximately 7.521 million yuan [1] Group 2 - Other domestic companies with registered status "A" for ketamine hydrochloride raw materials include Anhui Wanhe Pharmaceutical Co., Ltd. and Jiangsu Hengrui Medicine Co., Ltd. [1]